 Prevention alloimmunization patients acute leukemia use white cell-reduced blood components randomized trial Platelet refractoriness HLA alloimmunization serious complication transfusion therapy prospective trial white cell WBC blood components platelet red cell respect alloimmunization refractoriness platelet increments transfusion Sixteen adult acute leukemia patients WBC-reduced platelet concentrates PCs red cells RBCs unit Fifteen control patients standard blood components mean RBCs WBCs unit Platelet loss cotton-wool filtration percent range fresh PCs percent range PCs Filtration increments CI transfusion fresh PCs Cl hour filtration stored PCs percent difference hours survival WBC-reduced platelets number platelet units groups patient WBC-reduced group permanent platelet refractoriness transient HLA antibodies low titer patients control group patient refractory immunization transient HLA antibodies reduction WBCs blood components alloimmunization